Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin
- 1 June 1999
- Vol. 34 (6), 591-598
- https://doi.org/10.1007/s11745-999-0403-7
Abstract
Our previous studies showed that replacing the drinking water of rabbits fed a casein‐containing diet with either orange juice or grapefruit juice reduced serum low density lipoprotein cholesterol and hepatic cholesteryl ester concentrations. To determine whether the changes observed in rabbits were due to flavonoids present in the juices acting directly on the liver’ the effects of hesperetin and naringenin on net apolipoprotein B (apoB) secretion by HepG2 cells were investigated. These flavanones dose‐dependently reduced net apoB secretion by up to 81% after a 24 h incubation’ while doses of 60 μg/mL reduced net apoB secretion by 50% after 4 h. Coincubation with the proteasome inhibitor’ MG‐132’ did not alter the ability of the flavonoids to reduce net apoB secretion over 4 h’ suggesting that the flavonoid‐induced changes in apoB metabolism were not due to a direct increase in proteasomal activity. However’ the flavonoids were unable to reduce net apoB secretion after 4 h in the presence of oleate’ suggesting that these compounds may interfere with the availability of neutral lipids for lipoprotein assembly. Furthermore’ our 14C‐acetatelabeling studies showed a 50% reduction in cholesteryl ester synthesis in the presence of either flavonoid’ which could account for the reduction in net apoB secretion caused by incubation with these compounds. These in vitro studies suggest that hesperetin and naringenin may’ in part’ reduce net apoB secretion by HepG2 cells by inhibiting cholesteryl ester synthesis and that these compounds are good candidates for further in vivo studies to determine whether they are responsible for the cholesterol‐lowering properties of dietary citrus juices.This publication has 48 references indexed in Scilit:
- Inhibitory Effects of Oren-Gedoku-to and its Components on Cholesteryl Ester Synthesis in Cultured Human Hepatocyte HepG2 Cells: Evidence from the Cultured Hep2G Cells andIn VitroAssay of ACATPlanta Medica, 1997
- Decreased intracellular degradation and increased secretion of apo B-100 in Hep G2 cells after inhibition of cholesteryl ester synthesisAtherosclerosis, 1997
- ApoB-100 Secretion by HepG2 Cells Is Regulated by the Rate of Triglyceride Biosynthesis but Not by Intracellular Lipid PoolsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Ubiquitin-Proteasome Pathway Mediates Intracellular Degradation of Apolipoprotein BBiochemistry, 1996
- Rapid stimulation of apolipoprotein B secretion by oleate is not associated with cholesteryl ester biosynthesis in HepG2 cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Apo B metabolism in the cynomolgus monkey: evidence for post-transcriptional regulationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco-2 cells occurs post-transcriptionallyBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955